In vitro and in vivo activation of T cells was investigated T hybridoma cells. Nonprofessional APC expressing with invariant chain-antigen fusion protein. The CD4 T cell recombinant Ii HEL and H2-A k are also able to activate epitope amino acid 52-61 of hen egg lysozyme (HEL) was naive T cells from 3A9 TCR transgenic mice, a result not attached to the C-terminal end of invariant chain (Ii).
Introduction
MHC class II molecules are key structures on antigen presenting cells (APC) that trigger a T cell response against exogenous antigens. Antigenic peptides bind to the class II dimers and are presented on the cell surface to CD4 T cells. To make them available to the immune system, microorganisms like bacteria and other sources of exogenous antigens are internalized by APC and processed intracellularly. Intermediate-sized peptides of this antigenic digest bind to the class II peptide binding groove. This protects the peptide from further digestion. The biosynthetic route of class II molecules and the lysosomal degradation pathway of antigens intercept at endocytic vesicles. Here antigenic peptides are loaded on to class II dimers. The molecular mechanism of antigen processing and presentation depends on the function of molecules that transiently interact with class II molecules and facilitate binding of the antigen to the class II cleft. These co-players of antigen processing are Ii, MHC encoded DM and DO molecules and certain proteases. [1] [2] [3] [4] [5] [6] [7] An important role of Ii is to escort class II molecules to the endocytic route where Ii is degraded by cathepsin S or cathepsin L in MIIC vesicles. 7, 8 Along the transition from multivesicular to multilaminar MIICs, DM releases the remaining Ii fragment CLIP (class II-associated Ii peptides) from class II dimers and catalyzes the uptake of antigenic peptides. [9] [10] [11] [12] Many antigens such as tumor antigens and certain viral Correspondence: N Koch Received 12 April 1999; accepted 16 June 1999 antigens, are unable to elicit an efficient immune response. 13, 14 Generation of a protective immune response could be limited at the level of antigen processing and presentation to CD4 T cells. Thus, there is a substantial interest in intervening in the class II processing pathway. One option is to introduce CD4 T cell epitopes into this pathway by pulsing APC with protein or peptide. However, loading peptide from outside the cell does not lead to as efficient a presentation as supplying antigens on different carriers from inside the cell. 15 Different methods of supplying APC with antigenic epitopes have been devised. APC fed with soluble proteins such as Ig-peptide chimeras or following transfer of plasmid DNA from a bacterial carrier to the host elicit efficient antigen presentation to T cells. 16, 17 Kozono et al 18 produced chimeric peptide-class II proteins. APC expressing such recombinant proteins were able to stimulate T cell hybridomas to a greater extent than those pulsed with peptide. Chimeric molecules composed of cathepsin D and hen egg lysosome (HEL) were delivered by the Man-6-P receptor to the endosomal/lysosomal system.
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Ii fusion proteins have been used to target antigens to the class II presentation pathway either by transfection of DNA, by infection with adenovirus constructs, or by pulsing of APC with Ii fusion proteins. [20] [21] [22] [23] This strategy may allow peptide binding to class II antigens at an early stage of degradation and prevent potential over-digestion of peptide. The recombinant nature of these immunogens permits the use of virus or tumor antigens that otherwise would not be available for vaccination.
Dendritic cells are specialized in capturing and processing antigen to form MHC peptide complexes. 24 They elicit a primary T cell response and due to their migration to peripheral lymph nodes and their efficient activation of T cells, DC are capable of maintaining an immune response over the period necessary to eliminate invaded pathogens. 25 The phenotype of DC changes during maturation. Immature DC are efficient in the uptake and processing of antigen. The ability to process antigen is associated with a high rate of synthesis of class II molecules and Ii in immature DC or LC. Upon maturation of LC to DC, the biosynthesis of class II and Ii is diminished and the ability to process antigen rapidly declines while antigen presentation increases. 26, 27 Introduction of recombinant antigens into developing DC might facilitate the manipulation of the class II processing pathway for the purpose of presenting selected antigens.
We 
Results
Generation of recombinant Ii cDNA encoding a HEL T cell epitope The MHC class II-associated Ii is essential for presentation of some exogenous antigens. 1 Ii contains several functional domains, such as the class II binding site and a sorting signal that directs the class II/Ii complex to endocytic compartments and its delivery to MIIC vesicles. [28] [29] [30] At this location antigen loading to class II dimers takes place.
The HEL peptide aa 46-61 is the major CD4 T cell epitope for H2-A k -restricted T cells. This peptide binds with high affinity to H2-A k dimers. 31 The minimal peptide recognized by the 3A9 T hybridoma is the HEL sequence aa 52-61. 31 Further truncation of this sequence abolishes binding to H2-A k and stimulation of 3A9 T cells. This sequence was introduced into Ii by cloning the oligonucleotides encoding aa 52-61 of HEL into the DraIII site directly beyond the coding sequence of the Ii cDNA. The fusion protein (rIi HEL) encoded by this recombinant DNA is shown in Figure 1 . We tested whether this minimal epitope of HEL can be targeted to the class II processing pathway without being destroyed.
Maximal T cell stimulation by recombinant Ii HEL
A H2-A k L cell clone selected for low Ii expression was super-transfected with rIi HEL cDNA. Clones that express rIi HEL were selected by immunoprecipitation and inspected by cytofluorometry to express surface H2-A k comparable to the parental A k L cell clone (not shown). These clones were tested for their ability to stimulate the 3A9 T cell hybridoma. Activation of T cells was assessed by IL-2 release and subsequent proliferation of CTLL-2 indicator cells. Four L cell clones were tested and found to present the HEL epitope efficiently to 3A9 T cells (Figure 2a ). This indicates that the minimal HEL epitope is maintained upon degradation of Ii and presented to 3A9 T cells. Since Ii is degraded on the endocytic route, a single cleavage of the recombinant Ii at the C-terminus will release the HEL epitope. Thus the HEL epitope should be available for binding to class II dimers at an early stage of peptide exchange against CLIP. Since no variation between clones was observed, the following experiments were conducted with a single rIi HEL L cell clone.
We compared the response of 3A9 T hybridoma cells to L cells pulsed with different concentrations of HEL peptide with that to rIi HEL L cells. Figure 2b shows that the rIi HEL L cells stimulate IL-2 production by 3A9 T cells even better than L cells pulsed with up to 50 m HEL peptide. In this experiment cells were pulsed with peptide for 2 h and then washed to remove unbound peptide. Similar results were obtained with COS cells transiently transfected with H2-A k and rIi HEL cDNA (not shown). When APC are pulsed with exogenous antigen, only a proportion of recently synthesized class II molecules is loaded with processed peptide. In contrast, the antigen that is biosynthesized by the APC is capable of successively loading class II molecules, and thus maximally stimulating T cells, equivalent to that obtained in the presence of an excess of soluble antigen. Transient transfection of DC using rIi HEL cDNA If DC could be transfected with rIi HEL cDNA, these APC might trigger an immune response in vivo. It has been generally difficult to transfect DC and to attain high expression of the transgene. The detection of the recombinant HEL epitope by T cell hybridomas is highly sensitive and was used to optimize the transfection conditions. In addition, transgene expression was visualized by staining of rIi HEL in DC from Ii knockout mice with mAb against Ii. We found that within 18 h after transfection about 20% of the DC express rIi HEL (not shown). Subsequently, GM-CSF cultured bone marrow DC from CBA mice were transiently transfected with rIi HEL cDNA and cocultured with 3A9 T cells. Titration of rIi HEL cDNA transfected DC compared with untransfected DC, or Ii cDNA transfected DC, exhibit an antigendependent stimulation of 3A9 cells ( Figure 4a ).
As can be seen from 
Discussion
As in virus-infected cells where the class I pathway is flooded with antigen, in APC transfected with rIi HEL cDNA, the class II molecules are predominantly loaded with the HEL epitope. We used a single epitope of HEL contained in rIi HEL. This sequence is abundantly produced and bound to class II molecules before exogenous peptides derived from degraded antigens are available. The number of HEL peptides presented on these cells by class II dimers may increase the number of interactions with monospecific T cells which promotes T cell activation. Multivalent engagement of peptide/MHC complexes has been shown to crosslink TCRs and to initiate signal transduction. 32, 33 A multivalent binding of H2-A k /peptide complexes to TCR clusters could explain why rIi HEL L cells are capable of activating naive T cells from 3A9 transgenic mice. We cannot rule out, however, that the IL-2 response of 3A9 transgenic T cells was caused by crosspriming of some DC that had not been removed from the lymph node cell preparation. Recently, it has been shown, that after DNA injection dying keratinocytes can crossprime DC that subsequently induce a long lasting T cell response. 34 For many antigens sequence information is available, and generation of antigenic epitopes requires either the synthesis of the appropriate peptide or the production of recombinant polypeptides. Peptides can be used to pulse APC. However, binding studies showed that only a few percent of the class II bound ligands are exchanged by incubation with peptides. 35 These small numbers of class II/ligand complexes will decay in a short time. The high class II loading efficiency of our Ii fusion protein may increase the time-period when antigen is presented to T cells. A similar observation was found using an Ii-antigen fusion protein expressed by a nonreplicating adenovirus vector. The recombinant antigen was detectable as long as 4 weeks after injection into mice. 21 
Figure 2 Presentation of rIi HEL to T cell hybridomas. APC were cocultured with antigen-specific T cells. IL-2 containing culture supernatants were transferred to IL-2-dependent CTLL-2 cells. The figures show 3 Hthymidine incorporation by CTLL-2 cells. (a) H2-A k -transfected L cells were super-transfected with rIi HEL cDNA. Four L cell clones (1, 2, 5 and 12) which were identified by immuno-precipitation of rIi HEL, were used as APC to stimulate HEL aa 46-61-specific 3A9 T hybridoma cells (filled bars). H2-A k Ii L cells (L cells stably transfected with H2-A k and Ii DNA) without antigen (open bar) were used as background control. (b) Peptide-pulsed H2-A k Ii L cells were compared with H2-A k rIi HEL L cells (filled bar) in their presentation to 3A9 T hybridoma cells. H2-A k rIi HEL L cells present large amounts of the HEL T cell epitopes to 3A9 T hybridoma cells. H2-A k L cells pulsed with up to 50 m HEL peptide generate about half-maximal stimulation of 3A9 cells compared with H2-A k rIi HEL L cells. (c and d) 5 × 10 4 H2-A k Ii L cells per well were incubated with increasing concentrations of HEL peptide aa 46-61 or protein and presented to 3A9 T hybridoma cells (antigen was present during the incubation period). Stimulation with rIi HEL L cells were shown as filled bars. (e) H2-A k rIi HEL L cells fail to present a HEL epitope recognized by FH 135 T hybridoma cells. H2-A k rIi HEL L cells were incubated with increasing amounts of HEL protein and were used to stimulate FH 135 T hybridoma cells. H2-A k L cells transfected with rIi HEL (filled circles) display a low stimulation of FH 135 T hybridomas similar to L cells lacking Ii (open squares). H2-A k and Ii-transfected L cells (filled squares) stimulate FH 135 T cells in an antigen dose-dependent manner.
DC play a central role initiating an immune response. Hence, there is a great interest in studying the mechanism of antigen processing in these cells. Recent discoveries indicate that the regulation of Ii degradation by cathepsin S governs the surface expression of class II on DC. 36 The capture of antigen and subsequent migration to lymphoid organs are special features of dendritic cells. 37 Vaccination with transfected DC exploits these functional properties and allows antigens to be delivered to lymph nodes. 38 Once the DC has captured an antigen, the phenotype of the cell changes and accessory molecules important for T cell interaction appear on the cell surface. 39 Although class II surface expression increases, biosynthesis is not enhanced. In DC the export of class II molecules to the cell membrane is delayed by limited degradation of Ii in endocytic vesicles. In immature DC inefficient Ii cleavage restricts delivery of class II to the cell surface. By activation of cathepsin S in mature DC Ii is degraded and efficient transport of class II molecules to the plasma membrane occurs. 40 Our approach to transfect DC with rIi HEL cDNA makes use of the regulated cleavage of Ii. The degradation of Ii by cathepsin S makes class II dimers available for binding of peptides and simultaneously produces the HEL peptide by cleavage of rIi HEL. Our experiments show that while Ii is degraded, the minimal HEL epitope aa 52-61 remains stable and replaces CLIP in the H2-A k peptide binding groove. Bone marrow-derived DC transfected with rIi HEL were efficient presenters of the HEL epitope since immunization of mice with a low number of the recombinant DC induced antigen-specific proliferation of T cells in lymph nodes. Inspection of lymph nodes from mice immunized with peptide-pulsed or rIi HEL-transfected DC revealed
Figure 3 Activation of naive HEL-specific T cells by H2-A k rIi HEL L cells. Lymph node cells from 3A9 TCR transgenic mice were incubated with L cells that had been stably transfected with H2-A k rIi HEL (filled bar) or with H2-A k L cells pulsed for 2 h with increasing amounts of HEL peptide. After peptide pulsing the APC were washed and added to the T cells. Since IL-2 release was subsequently assessed, L cells were not treated with mitomycin C. Adherent cells were removed from the lymph node cells as described in Materials and methods. After 2 days of incubation, the supernatants were removed and added to IL-2-dependent CTLL-2 indicator cells. Proliferation of CTLL-2 cells was determined by 3 H-thymidine incorporation.
that the recombinant antigen induced larger lymph nodes with increased cell numbers (not shown). In a parallel study, fusion of Muc, a widely used tumor antigen, to Ii was employed for immunization of mice. A remarkable Muc-specific T cell response was obtained (Sponaas, unpublished).
Sanderson et al 20 described truncated Ii chains that were fused to ovalbumin or HEL sequences containing T cell epitopes. Both antigens were presented by transiently transfected COS cells and were found to stimulate antigen-specific T cells. However, since these recombinant Ii chains lack either the class II binding site, the trimerisation site or the endosomal sorting signal, it remains unclear whether the Ii fusion proteins enter the class II processing pathway or whether the antigens are captured from lysosomal degradation. Insertion of antigenic sequences at the end of the Ii chain has some advantage because the functional properties of Ii are retained. Other positions for insertion of antigenic sequences like the groove binding site of Ii might be useful to achieve loading of class II dimers early in biosynthesis. Binding of antigenic sequences that replace the groove binding segment of Ii to class II dimers has been demonstrated. 41 Similar constructs were also used for stimulation of T cells. 22 It might be interesting to use these constructs for vaccination studies. When the sequence of an antigenic epitope is not available, fusion of longer antigenic sequences that contain putative T cell epitopes to Ii could be employed to introduce antigens into the class II processing pathway. By generating various Ii-antigen constructs unknown T cell epitopes could be identified. The approach shown here for a murine model antigen might be useful for vaccination studies of patients with tumor or other antigens.
Materials and methods
Medium and chemicals L cell transfectants were grown in DMEM containing 10% FCS, 2 mm glutamine, 1 mm pyruvate, 100 U/ml penicillin and 100 g/ml streptomycin. T hybridomas were maintained in RPMI 1640 medium supplemented with 10% FCS, streptomycin, penicillin and glutamin at concentrations described above. 50 m 2-ME was also added. HEL was supplied by Sigma (Deisenhofen, Germany). HEL peptide 46-61 was a kind gift from Dr S Weiss, GBF, Braunschweig, Germany.
Constructs used for transfection
Oligonucleotides encoding amino acids (aa) 52-61 DYG-ILQINSR of HEL were cloned into the Ii cDNA in pcEXV-3 vector. This cDNA is under the control of the SV40 promoter and has been described previously. 28 The oligonucleotides were inserted beyond the last coding triplet into a unique DraIII site of Ii31 cDNA. The coding region of the Ii31 cDNA is maintained. The rIi HEL cDNA construct was characterized by restriction digest and was partially sequenced. The Ii fusion protein was characterized by immunoprecipitation.
Antigen presenting cells
Mouse fibroblast cells (L cells) transfected with H2-A k cDNA previously described were used. 42 A cell clone of cDNA. The transfectants were tested for Ii expression using immune precipitation with the Ii-specific mAb In1 (rat mAb) and MAR18.5 (mouse mAb anti-rat kappa light chain). 43, 44 rIi HEL expressing clones were further selected on the basis of the ability to stimulate the HEL-specific, H2-A k -restricted hybridoma 3A9. H2-A k L cells used as control APC had previously been transfected with genomic Ii DNA. 45 In vitro maturation of DC: GM-CSF cultured bone marrow DC were generated according to the protocol described. 46 Briefly, bone marrow cells were flushed out of femurs from 4-to 6-week-old mice, washed and cultured in IMDM containing 5% FCS and 250 U/ml recombinant mouse GM-CSF (a kind gift from Immunex, Seattle, WA, USA). After 2 days, non-adherent cells were gently removed. DC were further cultured with GM-CSF for another 8 days. The non-adherent cells were then harvested and used for experiments.
T cell hybridomas and cell lines
The following T cell hybridomas were used: a HEL 46-61 specific, H2-A k -restricted T cell hybridoma 3A9. 47 FH 135 is a T cell hybridoma specific for a not yet defined HEL epitope that is different to the epitope recognized by 3A9 cells (cells were a kind gift from Drs P Bertolino and C Rabourdin-Combe, Lyon, France). 48 CTLL-2 cells were purchased from ATCC and grown in IMDM medium (GIBCO/BRL, Karlsruhe, Germany) with 5% FCS, 2 mm glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 50 m 2-ME and 2 U/ml recombinant human IL-2 (Sigma). then used for immunization or antigen presentation, respectively. To determine transfection rates, transgene Ii expression was visualized by standard immunofluorescence assays using the mouse mAb In1 directed against the N terminal region of Ii.
Transient transfection of DC
Mice CBA/Ca mice were purchased from Harland Winkelman, (Borchen, Germany). Ii deficient mice were a kind gift from Drs C Benoist and D Mathis. 51 3A9 TCR transgenic mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). 
